NFKB1 and myelodysplastic syndrome: Furthermore, a high frequency of mutations in DNMT3A, TET2, ASXL1, and splicing factors, frequently identified in MDS and sAML, can influence the innate immune signaling and promote NF-κB signaling through various mechanisms [32,33,34].